Synopsis of recent research by authors named "Hongxian Wang"
Hongxian Wang's recent research primarily focuses on the interplay between molecular biomarkers and tumor behaviors in breast cancer, exploring cfDNA fragmentation and methylation profiles as potential diagnostic tools for the disease.
His studies also delve into the mechanisms underlying oncogenic factors like TWIST1 in triple-negative breast cancer, identifying specific phosphorylation pathways that could be targeted for therapeutic interventions.
Additionally, Wang investigates the use of novel long non-coding RNAs as diagnostic and prognostic biomarkers, integrating bioinformatics analyses to better understand their roles in breast cancer outcomes.
